Skip to content

To find out effect of syp.JTV in patients suffering from cough.

An open label, prospective, phase II,clinical study to evaluate efficacy and safety of syp.JTV in the bronchitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012516
Enrollment
36
Registered
2018-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Bronchitis cough Dysnoea sore throat Nasal congestion

Interventions

Intervention1: Syrup JTV: 10 ml twice daily with water for 15 days Control Intervention1: NIL: NIL

Sponsors

Aushadhi Bhavan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects with productive cough associated with acute bronchitis, dysnoea, wheezing, chest pain, sore throat, nasal congestion

Exclusion criteria

Exclusion criteria: Subjects with Diabetes Mellitus Type I and uncontrolled Diabetes Mellitus Type II, Subjects with uncontrolled Hypothyroidism or Hyperthyroidism, Known cases of Severe/Chronic Hepatic or Renal disease, any active malignancy. Subjects giving history of significant cardiovascular event Subjects X- ray chest showing any active lesion of tuberculosis and pnumonia. Subjects having severe bronchiectasis, Smokers cough, Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.

Design outcomes

Primary

MeasureTime frame
change in nature of sputum, frequency and severity of cough, breathlessness, Dysnoea, Wheezing, Chest pain, Sore throat and Nasal congestion from base line. Timepoint: 15 days

Secondary

MeasureTime frame
To study Changes in spirometry parameters from base line to last visit. To study safety of Syp JTV Timepoint: 15 days

Countries

India

Contacts

Public ContactDr Rajan Balwant Kulkarni

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik

vaidyarajankulkarni@gmail.com9823350440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026